CN1090628C - 新的n－芳基哌啶化合物,其制备方法和含有它们的药物组合物 - Google Patents

新的n－芳基哌啶化合物,其制备方法和含有它们的药物组合物 Download PDF

Info

Publication number
CN1090628C
CN1090628C CN98109437A CN98109437A CN1090628C CN 1090628 C CN1090628 C CN 1090628C CN 98109437 A CN98109437 A CN 98109437A CN 98109437 A CN98109437 A CN 98109437A CN 1090628 C CN1090628 C CN 1090628C
Authority
CN
China
Prior art keywords
dihydro
piperidin
fumarate
amine
benzo dioxine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN98109437A
Other languages
English (en)
Chinese (zh)
Other versions
CN1197072A (zh
Inventor
J·L·派格利昂
B·歌门特
M·米兰
A·格伯特
V·阿迪诺特
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Les Laboratoires Servier SAS
Original Assignee
Les Laboratoires Servier SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Les Laboratoires Servier SAS filed Critical Les Laboratoires Servier SAS
Publication of CN1197072A publication Critical patent/CN1197072A/zh
Application granted granted Critical
Publication of CN1090628C publication Critical patent/CN1090628C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D411/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Addiction (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CN98109437A 1997-03-27 1998-03-26 新的n－芳基哌啶化合物,其制备方法和含有它们的药物组合物 Expired - Fee Related CN1090628C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9703760 1997-03-27
FR9703760A FR2761358B1 (fr) 1997-03-27 1997-03-27 Nouveaux composes de n-aryl piperidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (2)

Publication Number Publication Date
CN1197072A CN1197072A (zh) 1998-10-28
CN1090628C true CN1090628C (zh) 2002-09-11

Family

ID=9505236

Family Applications (1)

Application Number Title Priority Date Filing Date
CN98109437A Expired - Fee Related CN1090628C (zh) 1997-03-27 1998-03-26 新的n－芳基哌啶化合物,其制备方法和含有它们的药物组合物

Country Status (17)

Country Link
US (1) US5965575A (2)
EP (1) EP0867436B1 (2)
JP (1) JPH10279578A (2)
CN (1) CN1090628C (2)
AT (1) ATE268767T1 (2)
AU (1) AU731018B2 (2)
BR (1) BR9803295A (2)
CA (1) CA2232116C (2)
DE (1) DE69824332T2 (2)
DK (1) DK0867436T3 (2)
ES (1) ES2223110T3 (2)
FR (1) FR2761358B1 (2)
NO (1) NO314628B1 (2)
NZ (1) NZ330041A (2)
PL (1) PL194118B1 (2)
PT (1) PT867436E (2)
ZA (1) ZA982607B (2)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2782515B1 (fr) * 1998-08-21 2000-09-22 Adir NOUVEAUX DERIVES DE L'INDANE-1-Ol, LEUR PROCEDE DE PREPARATION ET LES COMPOSITIONS PHARMACEUTIQUES QUI LES CONTIENNENT
TR200101939T2 (tr) * 1999-01-28 2002-05-21 Bristol-Myers Squibb Company Antidepresan heterosiklik bileşikler
ES2213022T3 (es) * 1999-06-30 2004-08-16 Bristol-Myers Squibb Company Derivados de aminopirrolidina heterociclicos utiles como agentes melatonergicos.
GB0013737D0 (en) 2000-06-07 2000-07-26 Astrazeneca Ab Novel compounds
SE0103646D0 (sv) * 2001-11-01 2001-11-01 Astrazeneca Ab Therapeutic chroman compounds
MXPA03006250A (es) 2001-01-16 2003-09-22 Astrazeneca Ab Compuestos heterociclicos terapeuticos.
NZ526699A (en) * 2001-01-16 2005-03-24 Astrazeneca Ab 8-amino derivatives and their use in treating migraine
SE0103650D0 (sv) * 2001-11-01 2001-11-01 Astrazeneca Ab Therapeutic heterocyclic compounds
WO2002069973A1 (en) * 2001-03-02 2002-09-12 Sepracor, Inc. Piperidine-piperazine ligand for neurotransmitter receptors
SE0103836D0 (sv) * 2001-11-16 2001-11-16 Astrazeneca Ab Novel compounds
JP2005343790A (ja) * 2002-05-31 2005-12-15 Ajinomoto Co Inc カルシウムチャネル拮抗薬を含有する医薬組成物
SE0300480D0 (sv) 2003-02-21 2003-02-21 Astrazeneca Ab Novel compounds
GB0312609D0 (en) 2003-06-02 2003-07-09 Astrazeneca Ab Novel compounds
KR20060030483A (ko) * 2003-06-30 2006-04-10 알타나 파마 아게 Ｐｄｅ10 억제제로서 피롤로디히드로이소퀴놀린
CA2530114A1 (en) * 2003-06-30 2005-01-13 Altana Pharma Ag Pyrrolo-dihydroisoquinoline derivatives as pde10 inhibitors
JP4591349B2 (ja) * 2003-07-14 2010-12-01 宇部興産株式会社 ４−アミノテトラヒドロピラン化合物及びその酸塩の製法、その合成中間体およびその製法
AR045258A1 (es) * 2003-08-21 2005-10-19 Altana Pharma Ag Un producto farmaceutico para inyeccion
US20060085924A1 (en) * 2004-10-13 2006-04-27 Gaelle Brun Coloring composition comprising at least one pigment and at least one electrophilic cyanoacrylate monomer
EP1838708A2 (en) * 2005-01-12 2007-10-03 Nycomed GmbH Pyrrolodihydroisoquinolines as antiproliferative agents
ATE430148T1 (de) * 2005-01-12 2009-05-15 Nycomed Gmbh Neue pyrrolodihydroisochinoline als pde10- inhibitoren
US8599822B2 (en) * 2005-03-23 2013-12-03 Cisco Technology, Inc. Slot-based transmission synchronization mechanism in wireless mesh networks
FR2884251B1 (fr) * 2005-04-08 2007-07-13 Servier Lab Derives de piperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
UY29892A1 (es) * 2005-11-04 2007-06-29 Astrazeneca Ab Nuevos derivados de cromano, composiciones farmaceuticas conteniendolos, procesos de preparacion y aplicaciones
AU2007254179B2 (en) 2006-05-18 2013-03-21 Pharmacyclics Llc Intracellular kinase inhibitors
WO2008114002A1 (en) 2007-03-22 2008-09-25 Astrazeneca Ab Quinoline derivatives for the treatment of inflammatory diseases
US8106073B2 (en) 2007-11-30 2012-01-31 Astrazeneca Ab Quinoline derivatives 057
TW200944523A (en) * 2008-02-08 2009-11-01 Organon Nv (Dihydro)pyrrolo[2,1-a]isoquinolines
WO2020183011A1 (en) 2019-03-14 2020-09-17 Institut Curie Htr1d inhibitors and uses thereof in the treatment of cancer

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995007274A1 (en) * 1993-09-06 1995-03-16 Knoll Ag Bicyclic aromatic compounds as therapeutic agents
US5464834A (en) * 1992-06-12 1995-11-07 Adir Et Compagnie N-substituted N'-heterobicyclic piperazines having pharmaceutical activity
EP0745598A1 (fr) * 1995-05-31 1996-12-04 Adir Et Compagnie Nouveaux composés de la pipérazine, de la pipéridine et de la 1,2,5,6-tétra-hydropyridine, leur procédé de préparation et les compositions pharmaceutiques les contenant

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5464834A (en) * 1992-06-12 1995-11-07 Adir Et Compagnie N-substituted N'-heterobicyclic piperazines having pharmaceutical activity
WO1995007274A1 (en) * 1993-09-06 1995-03-16 Knoll Ag Bicyclic aromatic compounds as therapeutic agents
EP0745598A1 (fr) * 1995-05-31 1996-12-04 Adir Et Compagnie Nouveaux composés de la pipérazine, de la pipéridine et de la 1,2,5,6-tétra-hydropyridine, leur procédé de préparation et les compositions pharmaceutiques les contenant

Also Published As

Publication number Publication date
DE69824332D1 (de) 2004-07-15
AU731018B2 (en) 2001-03-22
US5965575A (en) 1999-10-12
ES2223110T3 (es) 2005-02-16
DE69824332T2 (de) 2005-06-16
EP0867436A1 (fr) 1998-09-30
EP0867436B1 (fr) 2004-06-09
CA2232116A1 (fr) 1998-09-27
BR9803295A (pt) 2000-03-21
AU5967798A (en) 1998-10-01
PL194118B1 (pl) 2007-04-30
DK0867436T3 (da) 2004-10-04
HK1014954A1 (en) 1999-10-08
FR2761358A1 (fr) 1998-10-02
ATE268767T1 (de) 2004-06-15
NO981415L (no) 1998-09-28
CN1197072A (zh) 1998-10-28
NO981415D0 (no) 1998-03-27
PT867436E (pt) 2004-09-30
NZ330041A (en) 1999-01-28
PL325575A1 (en) 1998-09-28
ZA982607B (en) 1998-09-30
CA2232116C (fr) 2003-09-16
FR2761358B1 (fr) 1999-05-07
NO314628B1 (no) 2003-04-22
JPH10279578A (ja) 1998-10-20

Similar Documents

Publication Publication Date Title
CA2232116C (fr) Nouveaux composes de n-aryl piperidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CN102482251B (zh) 色酮衍生物、其制备方法及其治疗应用
JP3421323B2 (ja) ピペリジンｃｃｒ−３受容体拮抗薬
AU2004247559A1 (en) Benzamide derivative or salt thereof
JP2003508518A (ja) Ｃｎｓ疾患治療用のアミノアルコキシカルバゾール
CA2729217C (en) 6-substituted phenoxychroman carboxylic acid derivatives
CN1437597A (zh) 取代的苯基－哌嗪衍生物及其制备和用途
CN1090627C (zh) 2－氨基－1,2－二氢化茚化合物其制备方法和药物组合物
TWI360540B (en) Tetrahydroisoquinolylsulphonamide derivatives, the
CN1128144C (zh) 新的茚满－1－醇化合物，其制备方法及含有它们的药物组合物
JP2002504549A (ja) ベンジルピペラジニル−およびベンジルピペリジニルエタノン誘導体、その調製、およびドーパミンｄ４受容体アンタゴニストとしてのその使用
JP6943239B2 (ja) Ｋｃｎｑ２〜５チャネル活性化剤
JP2008509962A (ja) ５−ｈｔ７受容体アンタゴニスト
FR2791675A1 (fr) Derives de n-[2-(4-aminophenyl) ethyl] -2,3-dihydro-1,4- benzodioxinne-2-methanamine, leur preparation et leur application en therapeutique
JP2008509961A (ja) ５−ｈｔ７受容体アンタゴニスト
CN1304409A (zh) 用于治疗抑郁症的吲哚－3－基－环己胺衍生物(5－ht1受体拮抗剂)
KR100825040B1 (ko) 3-아릴-3-메틸-퀴놀린-2,4-디온 화합물, 약학적으로 허용가능한 이의 염, 이의 제조방법 및 이를 함유하는 약학적조성물
HK1014954B (en) New n-arylpiperidine compounds, a process for their preparation and pharmaceutical compositions containing them
CN1439004A (zh) 用于治疗中枢神经系统疾病的吲哚衍生物
ZA200204464B (en) Heteroaryl derivatives, their preparation and use.
CN1127501C (zh) 吲哚和2,3－二氢吲哚衍生物、它们的制备及用途
HK1014945B (en) 2-aminoindan compounds, a process for their preparation and pharmaceutical compositions containing them
JP2009514795A (ja) Ｎ−置換−１ｈ−キノリン−２，４−ジオン化合物、その製造方法及びそれを含む薬学的組成物
WO1991017144A1 (fr) Compose amide, utilisation pharmaceutique de ce compose et nouvelles pyrrolidinemethyl-amines 1-substituee
HK1026212B (en) New indan-1-ol compounds, a process for their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1045212

Country of ref document: HK

C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee